CN102558133B - Industrialized synthetic technology of 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine - Google Patents

Industrialized synthetic technology of 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine Download PDF

Info

Publication number
CN102558133B
CN102558133B CN201210030127.9A CN201210030127A CN102558133B CN 102558133 B CN102558133 B CN 102558133B CN 201210030127 A CN201210030127 A CN 201210030127A CN 102558133 B CN102558133 B CN 102558133B
Authority
CN
China
Prior art keywords
inferior
dimethylbenzene
reaction
dioxy phenyl
piperidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210030127.9A
Other languages
Chinese (zh)
Other versions
CN102558133A (en
Inventor
田保河
黄道孝
胡亚兰
王晓波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PLA 63975 ARMY
Original Assignee
PLA 63975 ARMY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PLA 63975 ARMY filed Critical PLA 63975 ARMY
Priority to CN201210030127.9A priority Critical patent/CN102558133B/en
Publication of CN102558133A publication Critical patent/CN102558133A/en
Application granted granted Critical
Publication of CN102558133B publication Critical patent/CN102558133B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Abstract

The invention belongs to an industrialized synthetic technology of 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine. The compound has anti-epileptic, anti-convulsions, anti-depression and other pharmacological activities, and the compound has been applied in treatment of epilepsy. The 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine is obtained by using heliotropin 2 as an initial raw material, carrying out condensation reaction on heliotropin 2 and propane diacid, and carrying out amidation reaction on heliotropin 2 and piperidine. The synthetic technology has the advantages of high yield, good purity, and easy operation, and is convenient for industrialized production, etc. The synthesis of the compound comprises the following equations.

Description

The industrial synthesis technique of a kind of 3-(3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin
Technical field
The present invention relates to the industrial synthesis technique of a kind of compound 3-(3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin, this compound has the pharmacologically actives such as anti-epileptic, anticonvulsion, antidepressant.
Background technology
Piperine (Piperine) is one of main effective constituent of plant pepper, and its chemical structure belongs to Cinnamamides, and research shows, this compounds has calmness, hypnosis, anticonvulsion and myorelaxant effects.3-(3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin (I) is the derivative of piperine, the antiepileptic drug that a kind of China that to be the eighties in last century Beijing scientific research personnel of department of pharmacy of medical college develop through piperine is carried out to composition optimizes has complete independent intellectual property right, clinical for the treatment of epilepsy.Clinical experiment shows, this medicine is applicable to various types of epilepticss, has the characteristics such as the anti-epilepsy of wide spectrum, high-efficiency low-toxicity, and the patient can relieved long-term taking, is particularly useful for children epilepsy patient and teenager epileptic.Further research shows, this compound also has stronger anticonvulsion, antidepressant activity, and Pharmacological Mechanism studies have shown that, this compound has the nerve ending of promotion to discharge 5-HT, increase the effect of the interior 5-HT of brain and DOPAMINE CONTENT IN RABBIT, thereby there is anticonvulsion, antidepressant effect.Therefore, this compound is with a wide range of applications.
Figure BSA00000668308100011
Document has been reported the synthetic of various Cinnamamides.Yang Hui in 1999 etc. have reported and have replaced the synthetic of Cinnamamide Deriv A Tives, under piperidines catalysis, substituted benzaldehyde and propanedioic acid are used the sulfur oxychloride chloride after condensation reaction generation replacement TRANSCINNAMIC ACID occurs in pyridine in benzene, obtain the Cinnamamide Deriv A Tives replaced through aminolysis reaction.Dish hawks in 2004 etc. have been reported intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-acrylic acid improvement synthetic method, take toluene as solvent, replace propanedioic acid with diethyl malonate, with piperonylaldehyde generation condensation reaction, under the catalysis of acetic acid and piperidines, through condensation, hydrolysis decarboxylation, synthesize and obtain.Zhang Qunying in 2006 etc. have reported the synthetic route improvement of aryl pyrimidines, take phenyl aldehyde as raw material, with the diacetyl oxide condensation, obtain TRANSCINNAMIC ACID, with after the sulfur oxychloride chloride, synthesizing and obtain aryl pyrimidines with the piperidines aminolysis again.In sum, Cinnamamides is to take aromatic aldehyde first to pass through the corresponding TRANSCINNAMIC ACID of condensation reaction synthetic intermediate as starting raw material, and then changes acyl chlorides into and carry out aminolysis with corresponding amine and obtain target compound.Therefore, 3-(3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin (I) can be synthesized through condensation reaction and amidate action two steps: the first step condensation reaction synthetic intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid (III), second step changes acyl chlorides into and carries out amidate action with piperidines again and obtain target compound.The synthetic method of two-step reaction is summarized as follows respectively:
One, take piperonylaldehyde (II) as raw material carries out condensation reaction synthetic intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid (III), can adopt three kinds of methods: diacetyl oxide method, diethyl malonate method and propanedioic acid method.In the diacetyl oxide method, adopt diacetyl oxide and piperonylaldehyde to carry out condensation, this step reaction needs comparatively high temps (approximately 140 ℃), long period (about 10h), strict anhydrous condition, and intermediate III need be carried out purifying through processes such as alkalization salify, decolouring, acidifying washings.In the diethyl malonate method, adopt toluene solvant can take away the water that reaction generates, reaction times, about 4h can complete condensation reaction, but obtaining is 3-(3 ', 4 '-inferior first dioxy phenyl)-diethyl malonate, still need to just can obtain intermediate III at hydrolysis decarboxylation under acidic conditions, increase reactions steps, operate complicated.In the propanedioic acid method, the temperature of reaction that propanedioic acid and piperonylaldehyde carry out condensation lower (lower than 100 ℃), reaction times shortens (about 2h) greatly, one step both can complete, and intermediate III only needs the acidifying washing to get final product purifying, and technique is simple, but decarboxylic reaction needs high temperature to complete (straight fire heating 0.5h left and right), there is certain danger in this reaction, is difficult for realizing industrialization.
Method one: diacetyl oxide method
Figure BSA00000668308100021
Method two: diethyl malonate method
Method three: propanedioic acid method
Figure BSA00000668308100023
In the second step amidate action, generally use the solvent of benzene as synthetic this class acid amides, but, because benzene is easy to be absorbed by human body alimentary canal, skin also there is a small amount of absorption, and be difficult to processing after discharge, cause environmental pollution.Bibliographical information is all to adopt sulfur oxychloride to carry out chloride to intermediate III, then obtains product with the piperylhydrazine solution.Usually the acyl chlorinating agent of carboxylic acid mainly contains sulfur oxychloride, phosphorus trichloride, phosphorus oxychloride, phosgene, oxalyl chloride etc., laboratory generally adopts sulfur oxychloride as acyl chlorinating agent, this reaction can be carried out at a lower temperature, byproduct of reaction is sulfurous gas and hydrogen chloride gas, be easy to remove from reaction, but the sulfur oxychloride activity is higher, remaining excess chlorination sulfoxide must be removed and just can carry out lower step aminolysis process, otherwise causes more by product to produce.Industrial normal employing phosphorus trichloride carries out chloride, and this reaction can be carried out equally at a lower temperature, and the by product phosphorous acid of reaction is easy to separate, and excessive a little phosphorus trichloride can not separate, and directly carries out aminolysis.
Figure BSA00000668308100031
Summary of the invention
The object of the present invention is to provide the industrial synthesis technique of the 3-that a kind of step is few, reaction efficiency is high (3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin.
Technical scheme of the present invention:
Adopting piperonylaldehyde (II) be starting raw material, through with the propanedioic acid condensation, obtaining intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid (III), then passes through chloride, reacts with piperidine amides and obtain target compound (I).
It has following reaction formula:
Figure BSA00000668308100032
1) condensation reaction: suction dimethylbenzene and pyridine in reactor, start stirring, drop into successively the piperidines of piperonylaldehyde (II), propanedioic acid and catalytic amount, open condenser condenses water, progressively heat up, 1~2h temperature rises to 80 ℃~100 ℃, keep temperature to stir 5~10h, change logical cold water temperature is down to below 50 ℃, stop stirring the whizzer rejection filter, it is 1~2 that filter cake is acidified to pH with concentrated hydrochloric acid, wash with water again to neutrality, rejection filter, be drying to obtain intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid (III);
2) amidate action: suction dimethylbenzene in reactor, start stirring, add successively again the first step intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid (III) and acylating agent, open condenser condenses water, progressively heat up, 1~2h temperature rises to 70 ℃~90 ℃, insulated and stirred 4-6h, be cooled to below 45 ℃, slowly drip piperidines under stirring, control temperature and be no more than 45 ℃, after adding, make temperature remain on 50~55 ℃ and stir 2h, stop heating, put to room temperature, reaction solution is first washed with weak ammonia, with dilute hydrochloric acid, wash again, finally remove dimethylbenzene under reduced pressure, the cooling crude product of separating out, crude product obtains required high purity 3-(3 ' with the dimethylbenzene recrystallization, 4 '-inferior first dioxy phenyl)-Antiepilepsirin (I).
Compare with the preparation method of existing 3-(3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin, the invention has the advantages that:
1. in condensation reaction, the present invention is improved on the basis of traditional propanedioic acid method, take piperidines as catalyzer, adopt pyridine and dimethylbenzene mixed solvent, make piperonylaldehyde and propanedioic acid generation condensation reaction and remove carboxyl to obtain intermediate III, reaction process relaxes, and a step completes, and has avoided the high temperature decarboxylation reaction of traditional propanedioic acid method;
2. in condensation reaction, the present invention adopts pyridine and dimethylbenzene mixed solvent, adopts the method for applying mechanically continuously, suitably adding, and has both reduced cost, has improved again yield.In mixed solvent, the volume ratio of pyridine and dimethylbenzene is 40~55%: 45~60%, and the use of mixed solvent can make two kinds of reactants all be easy to dissolve, to promote fully carrying out of reaction.The water generated in reaction constantly separates through water trap, to promote reaction, carries out fully.In production, mixed solvent adopts the method for applying mechanically continuously, suitably adding, and has both reduced cost, has improved again yield;
3. amidate action, the present invention selects dimethylbenzene as reaction solvent, can reduce as far as possible the harm of noxious solvent to people and environment;
4. in amidate action, piperidines drips excessively 100%~500%, both as reactant, participates in reaction, again as acid scavenger except the hydrogenchloride generated in dereaction, to impel acyl chlorides, react completely as far as possible, improve yield;
5. the mixed solvent that the present invention uses is reusable, and other reagent also is conventional reagent, and therefore production technique cost of the present invention is low, has good application prospect;
6. the invention provides the synthetic 3-(3 ' of an industrialization, the method of 4 '-inferior first dioxy phenyl)-Antiepilepsirin, the synthetic route design is easy, reasonable, obtain product by two-step reaction, each step reaction conditions gentleness, overall yield of reaction can reach more than 60%, is easy to scale operation, and has the stability of good suitability for industrialized production.
Embodiment
Following embodiment illustrates content of the present invention better.But the present invention is not limited to following embodiment.
3-(3 ', 4 '-inferior first dioxy phenyl)-acrylic acid synthetic
In the 300L reactor, suction 66L dimethylbenzene and 66L pyridine, start stirring, then drop into successively 72Kg piperonylaldehyde, 75Kg propanedioic acid and 5Kg piperidines, opens condenser condenses water.Start to heat up, the 1h left and right is warming up to 80 ℃ (interior temperature), and interior temperature remains on 80-85 ℃ and stirs 8h.Change logical cold water and make, below interior temperature drop to 45 ℃, to stop stirring, reaction mixture is put to the 60L plastic tank, cooling, placement is spent the night.Second day whizzer rejection filter, collect in order to the reaction of leaving office and apply mechanically filtrate merging.The white solid leached is put into to plastic tank, add 40L water, after mixing, under stirring, slowly add concentrated hydrochloric acid to adjust mixture pH=1~2, place 30min.Use the whizzer rejection filter, with tap water, be washed till filtrate pH=7, filter cake dries in shady and cool ventilation, and pulverizing, airtight package, obtain the 84Kg white solid, yield 91.1%.
synthesizing of 3-(3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin
In the 300L reactor, suction 180L dimethylbenzene, start stirring, drops into 14Kg 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid, opens condenser condenses water, then drops into the 9Kg phosphorus trichloride.Start to heat up, the 1h left and right is warming up to 75 ℃, and temperature remains on 75-80.℃ stir 4h.Change logical cold water and make, below interior temperature drop to 45 ℃, slowly to drip the 25Kg piperidines under stirring, control temperature and be no more than 45 ℃, after finishing, make interior temperature remain on 50-55 ℃ and stir 2h, stop heating, placement is spent the night.Second day adds 100L water in reactor, stirs 5min, standing 10min, after discarding water layer, organic phase is successively respectively with 95L water+5L ammoniacal liquor and 96L water+4L concentrated hydrochloric acid washing, and finally, with 100L washing twice, 5min is all stirred in each washing, standing 10min, discard water layer.Wash to finish the dimethylbenzene layer is proceeded in the 300L still kettle, start and stir and condenser condenses water, start heating, open reliever and carry out underpressure distillation, collect dimethylbenzene in order to reclaiming use.After collecting about 150L dimethylbenzene, resistates is put into to the 50L stainless steel cask, stir crystallisation by cooling, placement is spent the night.Within the 3rd day, use the whizzer rejection filter, dry the shady and cool ventilation of filter cake, pulverizes and obtain yellow solid 16Kg.Above-mentioned crude product is put in 48L dimethylbenzene, stirred and be heated to 60 ℃, insulation 30min after all dissolving, put into the 50L stainless steel cask, stir cooling crystallization, the whizzer rejection filter, naturally dry and obtain the 14.5Kg light yellow crystal, HPLC detects purity 99.8%, yield 76.8%. 1H?NMR(600MHz,CDCl 3):δ=1.61(m,4H);1.68(m,2H);3.61(d,4H);5.98(s,2H);6.73(d,1H);6.79(d,1H);6.99(dd,1H);7.03(d,1H);7.56(d,1H)。 13C?NMR(150MHz,CDCl 3):δ=24.9,25.8,27.0,43.5,47.2,101.6,106.6,108.7,115.9,123.8,130.2,142.1,148.4,149.0,165.6;CI-MS(m/z):260(M+1)。

Claims (3)

1. a 3-(3 ', the industrial synthesis technique of 4 '-inferior first dioxy phenyl)-Antiepilepsirin, it is characterized in that: adopt piperonylaldehyde (II) for starting raw material, through with the propanedioic acid condensation, obtaining intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid (III), then pass through chloride, react with piperidine amides and obtain 3-(3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin (I), synthetic route is as follows:
Figure FSB0000115231070000011
1) condensation reaction: suction dimethylbenzene and pyridine in reactor, the volume ratio of pyridine and dimethylbenzene is 40~55%:45~60%, start stirring, drop into successively piperonylaldehyde (II), the piperidines of propanedioic acid and catalytic amount, open condenser condenses water, progressively heat up, 1~2h temperature rises to 80 ℃~100 ℃, keep temperature to stir 5~10h, changing logical cold water is down to below 50 ℃ temperature, stop stirring, the whizzer rejection filter, it is 1~2 that filter cake is acidified to pH with concentrated hydrochloric acid, wash with water again to neutrality, rejection filter, be drying to obtain intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid (III),
2) amidate action: suction dimethylbenzene in reactor, start stirring, add successively again the first step intermediate 3-(3 ', 4 '-inferior first dioxy phenyl)-vinylformic acid (III) and acylating agent, open condenser condenses water, progressively heat up, 1~2h temperature rises to 70 ℃~90 ℃, insulated and stirred 4-6h, be cooled to below 45 ℃, slowly drip piperidines under stirring, piperidines excessive 100~500%, control temperature and be no more than 45 ℃, after adding, make temperature remain on 50~55 ℃ and stir 2h, stop heating, put to room temperature, reaction solution is first washed with weak ammonia, with dilute hydrochloric acid, wash again, finally remove dimethylbenzene under reduced pressure, the cooling crude product of separating out, crude product obtains required high purity 3-(3 ' with the dimethylbenzene recrystallization, 4 '-inferior first dioxy phenyl)-Antiepilepsirin (I).
2. the industrial synthesis technique of 3-as claimed in claim 1 (3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin, it is characterized in that: in described condensation reaction, the volume ratio of pyridine and dimethylbenzene mixed solvent is 40~55%: 45~60%; The feed ratio of propanedioic acid, piperonylaldehyde and piperidines is 14:15:1~20:15:1; The mixed solvent that reaction leaches after finishing can be applied mechanically continuously in the reaction of leaving office.
3. the industrial synthesis technique of 3-as claimed in claim 1 (3 ', 4 '-inferior first dioxy phenyl)-Antiepilepsirin, is characterized in that: in described amidate action, take dimethylbenzene as solvent; Acylating agent is a kind of in sulfur oxychloride, phosphorus trichloride, phosphorus oxychloride; Piperidines excessive 100~500%.
CN201210030127.9A 2012-02-13 2012-02-13 Industrialized synthetic technology of 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine Expired - Fee Related CN102558133B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210030127.9A CN102558133B (en) 2012-02-13 2012-02-13 Industrialized synthetic technology of 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210030127.9A CN102558133B (en) 2012-02-13 2012-02-13 Industrialized synthetic technology of 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine

Publications (2)

Publication Number Publication Date
CN102558133A CN102558133A (en) 2012-07-11
CN102558133B true CN102558133B (en) 2014-01-08

Family

ID=46404889

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210030127.9A Expired - Fee Related CN102558133B (en) 2012-02-13 2012-02-13 Industrialized synthetic technology of 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine

Country Status (1)

Country Link
CN (1) CN102558133B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103910709A (en) * 2014-03-05 2014-07-09 甘肃省农业科学院植物保护研究所 High-activity compound (E)-3-(3,4-methylenedioxophenyl)acrylic cyclohexanecarboxamide, and preparation method and application thereof
CN109867656A (en) * 2017-12-01 2019-06-11 北京斯利安药业有限公司 A kind of preparation method of Ilepcimide
CN110742077B (en) * 2019-11-11 2020-07-17 甘肃省农业科学院植物保护研究所 Application of cinnamate compound in preventing and treating crop fungal diseases
CA3213592A1 (en) * 2021-05-28 2022-12-01 Xiaohui Ma Antidepressant and anxiolytic substituted cinnamamide compound
CN113480513A (en) * 2021-06-24 2021-10-08 北京斯利安健康科技有限公司 Preparation method of ilexlyamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05262646A (en) * 1992-03-23 1993-10-12 Takeda Chem Ind Ltd Hepatic disorder-inhibiting agent

Also Published As

Publication number Publication date
CN102558133A (en) 2012-07-11

Similar Documents

Publication Publication Date Title
CN102558133B (en) Industrialized synthetic technology of 3-(3',4'-methylidynel dioxo phenyl)-acrylyl piperidine
CN104610250A (en) 1,2,3-thiadiazole-5-formamidine compound containing three N-heterocycles and synthesis
CN103755688A (en) Preparation method for afatinib compound
CN101891649A (en) Novel 3-cyano methyl benzoate preparing method
CN103420881B (en) A kind of preparation method of medicinal racemization hydroxyl Methionine calcium salt newly
CN106365986A (en) Compounds and preparation methods thereof, and uses of compounds in synthesis of brivaracetam
CN103694167A (en) Method for synthesizing flunixin meglumine
CN102558080B (en) Method for synthesizing thiotriazinone
CN100361972C (en) Synthesis of tenuazonic acid and iso-tenuazonic acid
CN103664923B (en) The preparation method of Nifuratel
CN102020584A (en) Method for synthesizing intermediate L-2-aminobutyrylamide hydrochloride of chiral drug levetiracetam
CN102101830A (en) Method for preparing trinexapac-ethyl
CN102391128B (en) Production method of antibiotic pharmaceutical intermediate mono-p-nitro benzyl malonate
WO2016037588A2 (en) New intermediate for synthesis of anti-aids drug enhancer cobicistat
CN111943862A (en) Preparation method of heart failure resistant drug Entresto key component Shakuba koji
CN102180864B (en) Preparation method of strontium ranelate
CN104497048A (en) Preparation method of minodronic acid
CN101585778A (en) A kind of preparation method of lyrica
CN103980144A (en) Nesting method for pregabalin intermediate mother liquor
CN105017158B (en) A kind of preparation method of cis Rosuvastatin calcium impurities
CN104876911A (en) Simple method for synthesizing delafloxacin
CN103172497A (en) Industrialized production process of new medicament benvitimod for treating psoriasis
CN101492388A (en) Method for synthesis of Miqujing medicament material
CN101891737A (en) Method for ammonolyzing and synthesizing meloxicam under catalysis of Lewis acid
CN109369494B (en) Preparation method of N-phenylacetyl-L-proline

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140108

Termination date: 20170213

CF01 Termination of patent right due to non-payment of annual fee